EDGAR Filing Documents for 0001104659-09-057375

Form 8-K - Current report:

SEC Accession No. 0001104659-09-057375

Filing Date

2009-10-02

Accepted

2009-10-01 17:49:50

Documents

Period of Report

2009-09-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a09-29410_18k.htm	8-K	47854
2	EX-4.1	a09-29410_1ex4d1.htm	EX-4.1	85262
3	EX-99.1	a09-29410_1ex99d1.htm	EX-99.1	17705
4	EX-99.2	a09-29410_1ex99d2.htm	EX-99.2	14185
5	GRAPHIC	g294101mmi001.jpg	GRAPHIC	3713
6	GRAPHIC	g294101mmi002.jpg	GRAPHIC	2163
7	GRAPHIC	g294101mni001.jpg	GRAPHIC	3870
	Complete submission text file	0001104659-09-057375.txt		180852

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725

Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771

Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)